Researchers from the University of Toronto have created a new multi-organ-on-a-chip device to investigate why the heart is one of the least common sites of cancer metastasis, creating new opportunities for cancer research and drug discovery.
The first findings reveal why heart tissue appears to limit the penetration of cancer cells, opening new avenues for research and development of treatments. A new technological platform, developed by researchers at the University of Toronto, aims to shed light on one of the biggest questions in oncology: why the heart is one of the least common organs for cancer metastases. The device, called the Multi-organ Invasion Device (MInD), allows the st…